Literature DB >> 22019260

Initial PSA oscillations precede prolonged stable disease in a patient treated with a therapeutic cancer vaccine.

Joseph W Kim1, Ravi A Madan, James L Gulley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22019260      PMCID： PMC3279569          DOI： 10.1016/j.clgc.2011.09.003

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  14 in total

1.  Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007).

Authors:  Mette Nørgaard; Annette Østergaard Jensen; Jacob Bonde Jacobsen; Kara Cetin; Jon P Fryzek; Henrik Toft Sørensen
Journal:  J Urol       Date:  2010-05-16       Impact factor: 7.450

Review 2.  The current and emerging role of immunotherapy in prostate cancer.

Authors:  Ravi A Madan; James L Gulley
Journal:  Clin Genitourin Cancer       Date:  2010-12-01       Impact factor: 2.872

3.  Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

Authors:  Philip W Kantoff; Celestia S Higano; Neal D Shore; E Roy Berger; Eric J Small; David F Penson; Charles H Redfern; Anna C Ferrari; Robert Dreicer; Robert B Sims; Yi Xu; Mark W Frohlich; Paul F Schellhammer
Journal:  N Engl J Med       Date:  2010-07-29       Impact factor: 91.245

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 5.  Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research.

Authors:  James L Gulley; Charles G Drake
Journal:  Clin Cancer Res       Date:  2011-06-15       Impact factor: 12.531

6.  Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

Authors:  Susan Halabi; Eric J Small; Philip W Kantoff; Michael W Kattan; Ellen B Kaplan; Nancy A Dawson; Ellis G Levine; Brent A Blumenstein; Nicholas J Vogelzang
Journal:  J Clin Oncol       Date:  2003-04-01       Impact factor: 44.544

7.  Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy.

Authors:  Wilfred D Stein; James L Gulley; Jeff Schlom; Ravi A Madan; William Dahut; William D Figg; Yang-Min Ning; Phil M Arlen; Doug Price; Susan E Bates; Tito Fojo
Journal:  Clin Cancer Res       Date:  2010-11-24       Impact factor: 12.531

Review 8.  Treatment of castration-resistant prostate cancer: updates on therapeutics targeting the androgen receptor signaling pathway.

Authors:  Wenhui Zhu; David S Zhu; Ravi A Madan; James L Gulley; William D Figg; William L Dahut
Journal:  Am J Ther       Date:  2010 Mar-Apr       Impact factor: 2.688

9.  Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

Authors:  Ian F Tannock; Ronald de Wit; William R Berry; Jozsef Horti; Anna Pluzanska; Kim N Chi; Stephane Oudard; Christine Théodore; Nicholas D James; Ingela Turesson; Mark A Rosenthal; Mario A Eisenberger
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

10.  Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.

Authors:  James L Gulley; Philip M Arlen; Ravi A Madan; Kwong-Yok Tsang; Mary P Pazdur; Lisa Skarupa; Jacquin L Jones; Diane J Poole; Jack P Higgins; James W Hodge; Vittore Cereda; Matteo Vergati; Seth M Steinberg; Susan Halabi; Elizabeth Jones; Clara Chen; Howard Parnes; John J Wright; William L Dahut; Jeffrey Schlom
Journal:  Cancer Immunol Immunother       Date:  2009-11-05       Impact factor: 6.968
View more
  1 in total

1.  Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial.

Authors:  Christopher R Heery; Ravi A Madan; Mark N Stein; Walter M Stadler; Robert S Di Paola; Myrna Rauckhorst; Seth M Steinberg; Jennifer L Marté; Clara C Chen; Italia Grenga; Renee N Donahue; Caroline Jochems; William L Dahut; Jeffrey Schlom; James L Gulley
Journal:  Oncotarget       Date:  2016-10-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.